Change search criteria ↓

Search results

21 projects found matching your search criteria:

  1. 1. Development of a group of non-basic ligands of serotonin receptor 5-HT7, derivatives of 2-(6-oxo-3-phenyl-1,6-dihydropyr…

    Principal investigator: dr Sabina Marta Podlewska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: SONATINA 2, Panel: NZ7

  2. 2. Targeting the serotonin 5-HT7 receptor in a search for new strategies of mental disorders treatment

    Principal investigator: Patryk Pyka

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 22, Panel: NZ7

  3. 3. Searching for the new lead structures for 5-HT7 serotonin receptor ligands with increased metabolic stability.

    Principal investigator: Sabina Marta Podlewska

    Instytut Farmakologii PAN

    Call: HARMONIA 7, Panel: NZ7

  4. 4. Changes in neurogenesis during withdrawal from nicotine self-administration in rats - role of serotonin (5-HT)2C recepto…

    Principal investigator: dr Magdalena Joanna Zaniewska

    Instytut Farmakologii PAN

    Call: OPUS 9, Panel: NZ4

  5. 5. Traizine 5-HT6 receptor ligands - new perspective for therapy of current civilization CNS-diseases

    Principal investigator: dr hab. Jadwiga Handzlik

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 9, Panel: NZ7

  6. 6. Development of a tool for automatic evaluation of complexes of ligands with serotonin receptors based on the application…

    Principal investigator: Sabina Marta Podlewska

    Instytut Farmakologii PAN

    Call: PRELUDIUM 5, Panel: NZ2

  7. 7. Probing the selectivity of zinc allosteric modulation in various serotonin receptor subtypes

    Principal investigator: Grzegorz Marek Satała

    Instytut Farmakologii PAN

    Call: PRELUDIUM 3, Panel: NZ7

  8. 8. Development of a comprehensive set of computational tools for the search of new ligands of particular receptor - case st…

    Principal investigator: dr hab. Sabina Marta Podlewska

    Instytut Farmakologii PAN

    Call: OPUS 16, Panel: NZ2

  9. 9. First-in-class dual biased agonists of serotonin 5-HT1A and dopamine D2 receptors – an innovative approach in the search…

    Principal investigator: prof. Marcin Roman Kołaczkowski

    Uniwersytet Jagielloński, Collegium Medicum

    Call: OPUS 21, Panel: NZ7

  10. 10. Anilide derivatives of long-chain cyclic amines as multifunctional serotonin receptors ligands and phosphodiesterase 7 i…

    Principal investigator: dr Agnieszka Wioleta Jankowska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: PRELUDIUM 13, Panel: NZ7

  11. 11. In the search for active compounds among ligands of serotonin, particularly 5-HT7, and dopamine receptors, with potentia…

    Principal investigator: prof. Anna Małgorzata Wesołowska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: OPUS 1, Panel: NZ4

  12. 12. Combination of FAAH inhibition with action via serotonin 5-HT6 receptor as pioneering approach to fight with Alzheimer D…

    Principal investigator: Kinga Maria Czarnota-Łydka

    Uniwersytet Jagielloński, Collegium Medicum

    Call: PRELUDIUM 21, Panel: NZ7

  13. 13. Novel hybrid 5-HT6 serotonin receptor and SERT transporter ligands as a therapeutic perspective of behavioural and cogni…

    Principal investigator: dr Agata Siwek

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: SONATA 14, Panel: NZ7

  14. 14. The determination of ADME-Tox in vitro for potential CNS-drug candidates acting as potent and selective ligands of serot…

    Principal investigator: Annamaria Teresa Lubelska

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Farmaceutyczny

    Call: PRELUDIUM 11, Panel: NZ7

  15. 15. Effect of paroxetine and risperidone on the heterodimerization of dopamine D2 and serotonin 5-HT1A receptor in the conte…

    Principal investigator: dr Magdalena Anna Kolasa

    Instytut Farmakologii PAN

    Call: PRELUDIUM 3, Panel: NZ7

  16. 16. The influence of muscarinic acetylcholine receptors (M1, M4 and M5) and serotonergic 5-HT1A receptor modulation on cogni…

    Principal investigator: dr Paulina Agnieszka Cieślik

    Instytut Farmakologii PAN

    Call: PRELUDIUM 16, Panel: NZ7

  17. 17. "I like to move it, move it" – molecular dynamics-driven optimization of ligand residence time as an opportunity to impr…

    Principal investigator: dr hab. Sabina Marta Podlewska

    Instytut Farmakologii PAN

    Call: OPUS 25, Panel: NZ7

  18. 18. Cooperative involvement of serotonergic signaling and extracellular matrix in synaptic plasticity underlying the pathoge…

    Principal investigator: dr hab. Jakub Mateusz Włodarczyk

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: HARMONIA 3, Panel: NZ3

  19. 19. Halogen bonding - the role and significance in interactions of ligands with class A GPCRs

    Principal investigator: dr Rafał Kurczab

    Instytut Farmakologii PAN

    Call: SONATA 8, Panel: NZ7

  20. 20. The significance of the serotonergic innervation of the brain hypothalamus in the regulation of cytochrome P450

    Principal investigator: prof. Władysława Anna Daniel

    Instytut Farmakologii PAN

    Call: OPUS 6, Panel: NZ7

  21. 21. Synthesis and biological evaluation of pyrrolidine-2,5-dione derivatives as potential antidepressant agents.

    Principal investigator: dr Andrzej Józef Chodkowski

    Warszawski Uniwersytet Medyczny, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej

    Call: OPUS 5, Panel: NZ7

Graphic design and implementation: Jakub Piotrowski